A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol

Recent evidence underscores the utility of rapid-acting antidepressant interventions, such as ketamine, in alleviating symptoms of major depressive episodes (MDE). However, to date, there have been limited hea...

Source: BMC Psychiatry - June 2, 2020 Category: Psychiatry Authors: Jennifer L. Phillips, Natalia Jaworska, Elizabeth Kamler, Venkat Bhat, Jean Blier, Jane A. Foster, Stefanie Hassel, Keith Ho, Lisa McMurray, Roumen Milev, Zahra Moazamigoudarzi, Franca M. Placenza, St éphane Richard-Devantoy, Susan Rotzinger, Gustavo Tur Tags: Study protocol Source Type: research